Novartis
NVS
NVS
1,172 hedge funds and large institutions have $24.4B invested in Novartis in 2019 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 412 increasing their positions, 387 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 1,089 → 1,172 (+83)
6% more repeat investments, than reductions
Existing positions increased: 412 | Existing positions reduced: 387
0.54% more ownership
Funds ownership: 9.57% → 10.11% (+0.54%)
Holders
1,172
Holding in Top 10
23
Calls
$200M
Puts
$129M
Top Buyers
| 1 | +$299M | |
| 2 | +$238M | |
| 3 | +$220M | |
| 4 |
Aristotle Capital Management
Los Angeles,
California
|
+$216M |
| 5 |
Renaissance Technologies
New York
|
+$132M |
Top Sellers
| 1 | -$148M | |
| 2 | -$56M | |
| 3 | -$50.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$47.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$47M |